Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7564099 | 1.00 | HPGD (0.37) | HPGDPARP1MEN1ALDH1A1TP53 | |
| SCHEMBL9750724 | 0.97 | HPGD (0.34) | HPGDPARP1MEN1ALDH1A1TP53 | |
| SCHEMBL10305806 | 0.87 | HPGD (0.34) | HPGDPARP1MEN1ALDH1A1TP53 | |
| SCHEMBL10447437 | 0.87 | HPGD (0.34) | HPGDPARP1MEN1ALDH1A1TP53 | |
| SCHEMBL10447629 | 0.87 | HPGD (0.34) | HPGDPARP1MEN1ALDH1A1TP53 | |
| SCHEMBL12972056 | 0.85 | HPGD (0.34) | HPGDPARP1MEN1ALDH1A1TP53 | |
| SCHEMBL3691224 | 0.85 | HPGD (0.33) | HPGDPARP1MEN1ALDH1A1TP53 | |
| SCHEMBL90746 | 0.83 | PARP1 (0.32) | HPGDPARP1 | |
| SCHEMBL19188768 | 0.83 | HPGD (0.33) | HPGDPARP1MEN1ALDH1A1TP53 | |
| SCHEMBL4383821 | 0.80 | HPGD (0.33) | HPGDPARP1MEN1ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3339406-A1 | FRAGRANCE COMPOSITION | International Flavors & Fragrances Inc. (US) | 2018-06-27 | — | — | EP | claimed |
| US-20180171264-A1 | NOVEL ORGANOLEPTIC COMPOUNDS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2018-06-21 | — | — | US | claimed |
| EP-1341512-A1 | RHINOLOGICAL AGENTS | HAARMANN & REIMER GMBH (DE) | 2003-09-10 | — | — | EP | claimed |
| WO-2002041861-A1 | RHINOLOGICAL AGENTS | HAARMANN & REIMER GMBH (DE) | 2002-05-30 | — | — | WO | claimed |
| CN-108203622-B | Organoleptic compounds | 国际香料和香精公司 | 2022-09-09 | — | — | CN | disclosed |
| EP-3339406-B1 | FRAGRANCE COMPOSITION | INT FLAVORS & FRAGRANCES INC (US) | 2020-02-12 | — | — | EP | disclosed |
| EP-3339406-A1 | FRAGRANCE COMPOSITION | International Flavors & Fragrances Inc. (US) | 2018-06-27 | — | — | EP | disclosed |
| CN-103201251-B | By the method for benzylamine compound initial preparation 2,2-difluoroethylamine | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-12-02 | — | — | CN | disclosed |
| EP-0284005-B1 | METHOD OF PRODUCTION OF POLYOLEFINS | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1991-12-18 | — | — | EP | disclosed |
| US-4981930-A | POLYMERIZATION CATALYSTS | IDEMITSU PETROCHEMICAL COMPANY LIMITED (JP) | 1991-01-01 | — | — | US | disclosed |
| EP-0284005-A2 | Method of production of polyolefins | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1988-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180171264-A1 | NOVEL ORGANOLEPTIC COMPOUNDS | TRPA1, TRPV1, TRPV5 | HPGD 1226/4885PARP1 3984/4885MEN1 3962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.